AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8001095 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonionic low osmolar contrast agent (iomeprol)
Number of subjects: 30
Study 8001095 — intervention group
Group type: COMPARATOR
Intervention: Ionic contrast agent (meglumine diatrizoate)
Number of subjects: 30
Study 3183633 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily acyclovir chemosuppression for 1 year
Number of subjects: 46
Study 3183633 — intervention group
Group type: COMPARATOR
Intervention: Intermittent acyclovir therapy (placebo group)
Number of subjects: 46
Study 15840666 — intervention group
Group type: EXPERIMENTAL
Intervention: THEO (theophylline) with loop diuretic (LD)
Number of subjects: 18
Study 15840666 — intervention group
Group type: COMPARATOR
Intervention: Normal saline placebo (NS) with loop diuretic (LD)
Number of subjects: 18
Study 31599810 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.04% polyhexanide
Number of subjects: 393
Study 31599810 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 393
Study 31599810 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative anemia
Number of subjects: 393
Study 31599810 — intervention group
Group type: EXPERIMENTAL
Intervention: More than 5 prior abdominal operations
Number of subjects: 393
Study 31163106 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline 50 mg/d and EPA 2 g/d
Number of subjects: 144
Study 31163106 — intervention group
Group type: COMPARATOR
Intervention: Sertraline 50 mg/d and corn oil placebo
Number of subjects: 144
Study 28855697 — intervention group
Group type: COMPARATOR
Intervention: Whey
Number of subjects: 5
Study 28855697 — intervention group
Group type: COMPARATOR
Intervention: Lactalbumin
Number of subjects: 5
Study 28855697 — intervention group
Group type: COMPARATOR
Intervention: Lactoferrin
Number of subjects: 5
Study 28855697 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 5
Study 26220802 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily electronic self-monitoring using smartphones for 6 months
Number of subjects: 78
Study 26220802 — intervention group
Group type: COMPARATOR
Intervention: Normal communicative purposes using smartphones for 6 months (Control)
Number of subjects: 78
Study 23171529 — intervention group
Group type: EXPERIMENTAL
Intervention: BW group
Number of subjects: 233
Study 23171529 — intervention group
Group type: COMPARATOR
Intervention: BW-BMI group
Number of subjects: 233
Study 23171529 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 233
Study 21704290 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine-based skin preparations followed by a cyanoacrylate-based skin sealant
Number of subjects: 300
Study 21704290 — intervention group
Group type: COMPARATOR
Intervention: Skin preparations alone
Number of subjects: 300
Study 19254970 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume-targeted ventilation at 4 mL/kg
Number of subjects: 20
Study 19254970 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume-targeted ventilation at 5 mL/kg
Number of subjects: 20
Study 19254970 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume-targeted ventilation at 6 mL/kg
Number of subjects: 20
Study 19254970 — intervention group
Group type: COMPARATOR
Intervention: Baseline (no volume targeting)
Number of subjects: 20
Study 16730188 — intervention group
Group type: EXPERIMENTAL
Intervention: Silzone valve
Number of subjects: 403
Study 16730188 — intervention group
Group type: COMPARATOR
Intervention: Control valve
Number of subjects: 403
Study 15299052 — intervention group
Group type: EXPERIMENTAL
Intervention: Perfusable tissue index (PTI) in DCM patients
Number of subjects: 15
Study 15299052 — intervention group
Group type: EXPERIMENTAL
Intervention: Coefficient of variation of PTI in DCM patients
Number of subjects: 15
Study 11291971 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 175
Study 11291971 — intervention group
Group type: COMPARATOR
Intervention: Vitamin E 400 units/day
Number of subjects: 175
Study 11291971 — intervention group
Group type: COMPARATOR
Intervention: Vitamin C 1,000 mg
Number of subjects: 175
Study 11291971 — intervention group
Group type: COMPARATOR
Intervention: Vitamin A 25,000 IU
Number of subjects: 175
Study 11291971 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 gm of fruit daily
Number of subjects: 175
Study 9253564 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 22
Study 9253564 — intervention group
Group type: COMPARATOR
Intervention: Patient controlled analgesia with morphine
Number of subjects: 22
Study 9253564 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil post-operative infusion
Number of subjects: 22
Study 8309924 — intervention group
Group type: EXPERIMENTAL
Intervention: VRP1 Desitin
Number of subjects: 51
Study 8309924 — intervention group
Group type: COMPARATOR
Intervention: Concomitant respiratory physiotherapy
Number of subjects: 51
Study 3755348 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 0.8 mg
Number of subjects: 10
Study 3755348 — intervention group
Group type: COMPARATOR
Intervention: Papaveretum i.v. (control group)
Number of subjects: 10
Study 30218318 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported monthly non-adherence (ring ever out, out for ≥12 hours)
Number of subjects: 1211
Study 30218318 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-rating scale assessing ability to keep the vaginal ring inserted
Number of subjects: 1211
Study 30218318 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite measure of non-adherence (plasma DPV value ≤95 pg/ml and residual ring ≥23.5 mg)
Number of subjects: 1211
Study 29421817 — intervention group
Group type: EXPERIMENTAL
Intervention: STW 5 (Iberogast)
Number of subjects: 980
Study 26908964 — intervention group
Group type: EXPERIMENTAL
Intervention: Delamanid, a new drug for the treatment of multidrug-resistant tuberculosis.
Number of subjects: 17
Study 25465642 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathlessness support service
Number of subjects: 105
Study 25465642 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 105
Study 22951761 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based rehabilitation
Number of subjects: 49
Study 22951761 — intervention group
Group type: COMPARATOR
Intervention: Center-based rehabilitation
Number of subjects: 49
Study 22951761 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 49
Study 19297246 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential oil gargle (2 drops of a 1:1 mix of manuka and kanuka essential oils in water)
Number of subjects: 19
Study 19297246 — intervention group
Group type: COMPARATOR
Intervention: Placebo (gargling with water)
Number of subjects: 19
Study 19297246 — intervention group
Group type: COMPARATOR
Intervention: Control ('usual care')
Number of subjects: 19
Study 17492425 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate alcohol consumption (100 ml whisky, approximately 32 g alcohol daily for 4 weeks)
Number of subjects: 19
Study 17492425 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate alcohol consumption
Number of subjects: 19
Study 15726874 — intervention group
Group type: EXPERIMENTAL
Intervention: Talinolol 200 mg once daily
Number of subjects: 241
Study 15726874 — intervention group
Group type: EXPERIMENTAL
Intervention: Talinolol 300 mg once daily
Number of subjects: 241
Study 15726874 — intervention group
Group type: EXPERIMENTAL
Intervention: Talinolol 100 mg once daily
Number of subjects: 241
Study 15726874 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 241
Study 11430849 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk family study
Number of subjects: 0
Study 9678319 — intervention group
Group type: EXPERIMENTAL
Intervention: APOE epsilon4 genotype (APOE epsilon4/4)
Number of subjects: 28
Study 7985595 — intervention group
Group type: EXPERIMENTAL
Intervention: Flosequinan
Number of subjects: 39
Study 7985595 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 2532533 — intervention group
Group type: EXPERIMENTAL
Intervention: Mivacurium infusion during halothane anaesthesia
Number of subjects: 28
Study 2532533 — intervention group
Group type: EXPERIMENTAL
Intervention: Mivacurium infusion during opioid anaesthesia
Number of subjects: 28
Study 2532533 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery index for all patients after discontinuing the infusion
Number of subjects: 28
Study 4913785 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrazepam (5 mg)
Number of subjects: 0
Study 4913785 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrazepam (10 mg)
Number of subjects: 0
Study 4913785 — intervention group
Group type: EXPERIMENTAL
Intervention: Amylobarbitone sodium (100 mg)
Number of subjects: 0
Study 4913785 — intervention group
Group type: EXPERIMENTAL
Intervention: Amylobarbitone sodium (200 mg)
Number of subjects: 0
Study 4913785 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31103109 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi Chuan training (6 weeks, 18 sessions, 60 minutes each)
Number of subjects: 18
Study 31103109 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 18
Study 29036257 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical DNA repair enzyme lotion applied twice daily for 8 weeks
Number of subjects: 15
Study 29036257 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Eucerin Professional lotion) applied twice daily for 8 weeks
Number of subjects: 15
Study 25886894 — intervention group
Group type: EXPERIMENTAL
Intervention: Standing work (SW)
Number of subjects: 32
Study 25886894 — intervention group
Group type: COMPARATOR
Intervention: Control (CONT)
Number of subjects: 32
Study 23333022 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily Cone Beam Computed Tomography (CBCT)
Number of subjects: 208
Study 23333022 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily Electronic Portal Imaging with Fiducial Markers (EPI-FM)
Number of subjects: 208
Study 23333022 — intervention group
Group type: COMPARATOR
Intervention: Weekly controls (CBCT and EPI-FM)
Number of subjects: 208
Study 21256073 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific treatment based on the Movement System Impairment (MSI) model
Number of subjects: 32
Study 21256073 — intervention group
Group type: COMPARATOR
Intervention: Non-Specific treatment
Number of subjects: 32
Study 19762766 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 75
Study 19762766 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine
Number of subjects: 75
Study 19762766 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine
Number of subjects: 75
Study 19762766 — intervention group
Group type: COMPARATOR
Intervention: Levobupivacaine/Bupivacaine
Number of subjects: 75
Study 19762766 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine/Bupivacaine
Number of subjects: 75
Study 19762766 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine/Levobupivacaine
Number of subjects: 75
Study 18175830 — intervention group
Group type: EXPERIMENTAL
Intervention: Local phototherapy (one-time treatment)
Number of subjects: 36
Study 18175830 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse current exposure (2-3 times a week for 30-40 minutes)
Number of subjects: 36
Study 18175830 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 36
Study 15180615 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater alcohol intake
Number of subjects: 34694
Study 15180615 — intervention group
Group type: EXPERIMENTAL
Intervention: Current tobacco use
Number of subjects: 34694
Study 15682975 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of rifampicin for chemoprophylaxis
Number of subjects: 21867
Study 15682975 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21867
Study 10510918 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg morphine sulfate (MS)
Number of subjects: 74
Study 10510918 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg ketorolac tromethamine (KT)
Number of subjects: 74
Study 10510918 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 2.5% lidocaine/prilocaine gel (Emla)
Number of subjects: 74
Study 10510918 — intervention group
Group type: COMPARATOR
Intervention: Ureteral stents (n = 32)
Number of subjects: 74
Study 7856707 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 gel
Number of subjects: 66
Study 7856707 — intervention group
Group type: COMPARATOR
Intervention: Foley catheter
Number of subjects: 66
Study 7856707 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 66
Study 1883120 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril plus conventional antihypertensives
Number of subjects: 73
Study 1883120 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus conventional antihypertensives
Number of subjects: 73
Study 6455463 — intervention group
Group type: EXPERIMENTAL
Intervention: Nuva-Seal
Number of subjects: 220
Study 6455463 — intervention group
Group type: COMPARATOR
Intervention: Delton
Number of subjects: 220
Study 31085814 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D and calcium supplementation
Number of subjects: 165
Study 31085814 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study 30171915 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal stimulation over the right inferior frontal gyrus (rIFG) with cathodal stimulation over the left IFG
Number of subjects: 23
Study 30171915 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 23
Study 26724841 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3090
Study 26724841 — intervention group
Group type: COMPARATOR
Intervention: 0.5 mg of dutasteride
Number of subjects: 3090
Study 24630937 — intervention group
Group type: EXPERIMENTAL
Intervention: Vignette describing late blight
Number of subjects: 859
Study 24630937 — intervention group
Group type: COMPARATOR
Intervention: Vignette about generic crop disease
Number of subjects: 859
Study 24630937 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived risks of GM to human and environmental health
Number of subjects: 859
Study 24630937 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived benefits of GM (e.g. reduced threats to crops and a more secure food supply)
Number of subjects: 859
Study 24630937 — intervention group
Group type: EXPERIMENTAL
Intervention: Objective knowledge about GM
Number of subjects: 859
Study 24630937 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐assessed familiarity with GM
Number of subjects: 859
Study 22466467 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine with 75 IU of hyaluronidase as peribulbar injection of 5 mL before surgery
Number of subjects: 60
Study 22466467 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine with 75 IU of hyaluronidase as peribulbar injection of 1 mL or 3 mL before surgery
Number of subjects: 60
Study 22466467 — intervention group
Group type: COMPARATOR
Intervention: Control group (30 patients without any additional analgesic treatment)
Number of subjects: 60
Study 22466467 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine with 75 IU of hyaluronidase as peribulbar injection of 5 mL after surgery
Number of subjects: 60
Study 20138043 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsule endoscopy
Number of subjects: 136
Study 20138043 — intervention group
Group type: COMPARATOR
Intervention: Dedicated small bowel radiography
Number of subjects: 136
Study 18039077 — intervention group
Group type: EXPERIMENTAL
Intervention: High-loading dose regimen of liposomal amphotericin B (L‐AMB)
Number of subjects: 0
Study 18039077 — intervention group
Group type: COMPARATOR
Intervention: Standard dosing regimen of liposomal amphotericin B (L‐AMB)
Number of subjects: 0
Study 16082239 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo Care (skin‐to‐skin contact) during heel stick
Number of subjects: 24
Study 16082239 — intervention group
Group type: COMPARATOR
Intervention: Heel stick in the warmer
Number of subjects: 24
Study 16082239 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo Care (skin‐to‐skin contact)
Number of subjects: 24
Study 12124952 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-atrial infusion of heparin and tissue plasminogen activator (t-PA)
Number of subjects: 30
Study 12124952 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin and streptokinase
Number of subjects: 30
Study 12124952 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin
Number of subjects: 30
Study 12124952 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention)
Number of subjects: 30
Study 10417578 — intervention group
Group type: EXPERIMENTAL
Intervention: 950 microsec dwell time CO2 laser
Number of subjects: 20
Study 10417578 — intervention group
Group type: COMPARATOR
Intervention: Baker's phenol
Number of subjects: 20
Study 7483799 — intervention group
Group type: EXPERIMENTAL
Intervention: Three doses of oral poliomyelitis (OPV) and diphtheria and tetanus (DTV) vaccines
Number of subjects: 243
Study 7483799 — intervention group
Group type: EXPERIMENTAL
Intervention: Three doses of OPV and DTV vaccines plus recombinant hepatitis B vaccine (HBV)
Number of subjects: 243
Study 7483799 — intervention group
Group type: EXPERIMENTAL
Intervention: HBV recombinant vaccine alone
Number of subjects: 243
Study 31567484 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromyography-triggered neuromuscular electrical stimulation training (single electrical stimulation group)
Number of subjects: 36
Study 31567484 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined electromyography-triggered neuromuscular electrical stimulation and tilt sensor functional electrical stimulation training (combined electrical stimulation group)
Number of subjects: 36
Study 31567484 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study 28187529 — intervention group
Group type: EXPERIMENTAL
Intervention: Timed Up & Go test (TUG)
Number of subjects: 0
Study 28187529 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee extension strength
Number of subjects: 0
Study 28187529 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength asymmetry
Number of subjects: 0
Study 25907146 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastrocnemius stretching combined with joint mobilization
Number of subjects: 24
Study 25907146 — intervention group
Group type: COMPARATOR
Intervention: Gastrocnemius stretching alone
Number of subjects: 24
Study 23244654 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention program for primary prevention of asthma applied during the first year of life
Number of subjects: 373
Study 23244654 — intervention group
Group type: EXPERIMENTAL
Intervention: Early-onset AD (16.6% prevalence during the first 2 years)
Number of subjects: 373
Study 23244654 — intervention group
Group type: EXPERIMENTAL
Intervention: Late-onset AD (6.2% prevalence after age 2)
Number of subjects: 373
Study 23244654 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent AD
Number of subjects: 373
Study 23244654 — intervention group
Group type: EXPERIMENTAL
Intervention: Early-onset AD (persistent or nonpersistent)
Number of subjects: 373
Study 21498489 — intervention group
Group type: EXPERIMENTAL
Intervention: Immobilization in internal rotation for three weeks
Number of subjects: 188
Study 21498489 — intervention group
Group type: COMPARATOR
Intervention: Immobilization in external rotation for three weeks
Number of subjects: 188
Study 19192030 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-glycaemic index beverage
Number of subjects: 6
Study 19192030 — intervention group
Group type: COMPARATOR
Intervention: Control (sucrose-based beverage)
Number of subjects: 6
Study 16775229 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolmitriptan 2.5 mg
Number of subjects: 32
Study 16775229 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 200 to 400 mg
Number of subjects: 32
Study 16775229 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 15363423 — intervention group
Group type: EXPERIMENTAL
Intervention: rhBMP-2 on an absorbable collagen sponge
Number of subjects: 67
Study 15363423 — intervention group
Group type: COMPARATOR
Intervention: Autogenous iliac crest bone graft
Number of subjects: 67
Study 11293641 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg erythromycin
Number of subjects: 6295
Study 11293641 — intervention group
Group type: EXPERIMENTAL
Intervention: 325 mg co-amoxiclav (250 mg amoxicillin and 125 mg clavulanic acid)
Number of subjects: 6295
Study 11293641 — intervention group
Group type: EXPERIMENTAL
Intervention: both antibiotics (erythromycin and co-amoxiclav)
Number of subjects: 6295
Study 11293641 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 6295
Study 9048720 — intervention group
Group type: EXPERIMENTAL
Intervention: Type II fibre predominance in muscle biopsy
Number of subjects: 37
Study 9048720 — intervention group
Group type: EXPERIMENTAL
Intervention: Constant treadmill work load test
Number of subjects: 37
Study 9048720 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood lactate measurement
Number of subjects: 37
Study 15278789 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 27
Study 15278789 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 27
Study 15278789 — intervention group
Group type: EXPERIMENTAL
Intervention: Enflurane
Number of subjects: 27
Study 3013123 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous absorbable suture (No. 2, coated, polyglycolic acid suture - Dexon‐Plus)
Number of subjects: 105
Study 3013123 — intervention group
Group type: COMPARATOR
Intervention: Interrupted nonabsorbable suture (No. 28 monofilament stainless steel wire)
Number of subjects: 105
Study 31725608 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation of blindness using a sleep mask for 45 minutes, split into 3 periods of 15 minutes each.
Number of subjects: 0
Study 31725608 — intervention group
Group type: COMPARATOR
Intervention: Normal vision group (Group i)
Number of subjects: 0
Study 31725608 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual impairment group (Group ii)
Number of subjects: 0
Study 28279371 — intervention group
Group type: EXPERIMENTAL
Intervention: High lipid content in carotid plaques
Number of subjects: 214
Study 28279371 — intervention group
Group type: EXPERIMENTAL
Intervention: Thin/ruptured fibrous cap in carotid plaques
Number of subjects: 214